|
Conducting
a pre-transplant liver biopsy on a prospective donor can lead
to the discovery of potential complications and improve prospects
for a successful living-donor liver transplant, according to researchers
at Cedars-Sinai Medical Center in Los Angeles.
The researchers
say the biopsy -- required as a pre-transplant screening test
by only about ten percent of U.S. centers performing living-donor
liver transplants -- can detect abnormalities in potential liver
donors that might go unnoticed through the usual laboratory and
imaging tests.
"We want
to avoid operating on donors whose livers are ultimately unacceptable
for transplant, and we want the patient to achieve the best result
possible after the transplant is completed," said Dr. Tram
Tran, assistant director of the Liver Transplant Program at Cedars-Sinai.
Reporting
on 56 donors who donated a lobe of their liver in the Cedars-Sinai
living donor liver transplant program between May 2001 and Oct.
2002, Tran said all 56 showed no obvious abnormalities in screenings
that included physical exams, extensive blood testing, imaging
and further clinical evaluations.
But subsequent
biopsies found chronic hepatitis, severe fat in the liver and
other liver complications in some of the prospective donors that
would not have been detected without the liver biopsy. Tran said
only 27 percent of these donors had livers as healthy as the screenings,
alone, had indicated.
"We feel
that a donor biopsy is very valuable in detecting abnormalities
that we might miss through routine screenings," said Tran.
"We recognize that there is a one percent risk of bleeding
with a liver biopsy but we feel the risk is justified in that
the lives of two people are at stake."
"Based
on the results of our analysis, we're now recommending that all
centers offering living donor liver transplants consider adding
a pre-transplant donor biopsy to their screening process,"
said Dr. John Vierling, Medical Director of the Multi-Organ Transplant
Program at Cedars-Sinai.
Other
Sources: Cedars-Sinai
|